Hans E. Grossniklaus

This paper develops a collagen-targeting MRI contrast agent to noninvasively detect early fibrosis in ADPKD, showing improved detection compared to standard agents.

This study identifies HIFN, a novel TrkB activator, which improves visual function and retinal neuron survival in a mouse model of ocular trauma.

This study shows that PEDF deficiency in mice increases light-induced retinal damage, with worsened visual function, retinal thinning, and Galectin-3 expression.

A magnetic cell therapy reduced intraocular pressure in a glaucoma mouse model, with hAMSCs showing greater efficacy than iPSC-TM cells.